Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 92%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,127
Total Claims
$804K
Drug Cost
803
Beneficiaries
$1,001
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-8%
Opioid rate vs peers
2.4% vs 2.6% avg
-6%
Cost per patient vs peers
$1,001 vs $1,068 avg
+33%
Brand preference vs peers
12.0% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.4%
Opioid Rate
241
Opioid Claims
$2,438
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,201 claims · $625K
Generic: 8,808 claims · $167K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 121 | $105K |
| Insulin Glargine,hum.Rec.Anlog | 88 | $70K |
| Dulaglutide | 53 | $58K |
| Rivaroxaban | 39 | $39K |
| Insulin Aspart | 33 | $31K |
| Insulin Glargine,hum.Rec.Anlog | 14 | $24K |
| Eluxadoline | 13 | $19K |
| Empagliflozin | 20 | $19K |
| Insulin Lispro | 24 | $17K |
| Liraglutide | 19 | $16K |
| Semaglutide | 14 | $13K |
| Linaclotide | 24 | $13K |
| Insulin Aspart | 17 | $13K |
| Fluticasone Propionate | 30 | $13K |
| Levothyroxine Sodium | 446 | $8,104 |
Prescribing Profile
Patient Profile
73
Avg Age
53%
Female
1.08
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About